1037 — Maxnerva Technology Services Cashflow Statement
0.000.00%
- HK$342.49m
- HK$225.21m
- CNY707.58m
Annual cashflow statement for Maxnerva Technology Services, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | — |
| Source: | ARS | ARS | ARS | ARS | |
| Standards: | HKAS | HKAS | HKAS | HKAS | — |
| Status: | Final | Final | Final | Final | fx Preliminary |
| Net Income/Starting Line | 37.6 | 30.5 | -14.2 | -9.06 | — |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -6.56 | 4.72 | 19.1 | 11.6 | — |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -37.9 | -32.3 | 12.3 | -1.67 | — |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 15.1 | 22.1 | 32.8 | 10.7 | — |
| Capital Expenditures | -3.83 | -1.75 | -1.53 | -12 | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -13.7 | -31.5 | — | 0.166 | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -17.5 | -33.2 | -1.53 | -11.9 | — |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -14.4 | -16.4 | -10.1 | -4.52 | — |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -23.4 | -22.2 | 22.9 | -3.47 | — |